{'Year': '2024', 'Month': 'May', 'Day': '01'}
Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia.
Disparities in outcomes exist between Black and White patients with acute myeloid leukemia (AML), with Black patients experiencing poorer prognosis compared with their White counterparts.